PT DANKOS FARMA — Salmeterol Importer Profile
Pharmaceutical Importer · #17 buyer for Salmeterol · $531.1K import value · 13 shipments · INDONESIA · DGFT Verified
PT DANKOS FARMA is the #17 importer of Salmeterol from India with $531.1K in import value and 13 verified shipments. PT DANKOS FARMA holds a 0.9% market share in Salmeterol imports based in INDONESIA. The company sources from 1 verified supplier across 4 formulations shipped to 1 country.
PT DANKOS FARMA — Salmeterol Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Salmeterol to PT DANKOS FARMA?
Verified from 13 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $531.1K | 13 | 100.0% |
PT DANKOS FARMA sources Salmeterol from 1 verified Indian supplier based on 13 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.
How Does PT DANKOS FARMA Compare to Nearest Salmeterol Importers?
Buyers ranked immediately above and below #17 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | CIPLA AUSTRALIA PTY LTD, | AUSTRALIA | $950.0K | 19 | $50.0K |
| 16 | CONSIGNMENT STOCK OF S&D PHARMA CZ | NETHERLANDS | $849.1K | 27 | $31.4K |
| 17 | PT DANKOS FARMA ★ | INDONESIA | $650.0K | 13 | $50.0K |
| 10 | PHARMAX PHARMACEUTICALS FZ LLC | UNITED ARAB EMIRATES | $550.0K | 11 | $50.0K |
| 5 | SANDOZ PTY LTD. SANDOZ | AUSTRALIA | $500.0K | 10 | $50.0K |
PT DANKOS FARMA ranks #17 among 370 Salmeterol importers from India. Average shipment value of $50.0K compared to the market average of $61.5K. The closest competitors by value are CIPLA AUSTRALIA PTY LTD, and CONSIGNMENT STOCK OF S&D PHARMA CZ.
Where Does PT DANKOS FARMA Import Salmeterol To?
Destination countries from 13 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| INDONESIA | $531.1K | 13 | 100.0% |
PT DANKOS FARMA imports Salmeterol to 1 country. The primary destination is INDONESIA receiving 100.0% of shipments worth $531.1K.
What Salmeterol Formulations Does PT DANKOS FARMA Import?
| Formulation | Value | Shipments |
|---|---|---|
| FLUTIAS 125 INHALER ( SALMETEROL XINAFOA | $300.0K | 6 |
| FLUTIAS 125 INHALER (SALMETEROL XINAFOATE 25MCG+FLUTICASONE PROPIONATE 125MCG) 22855 PACK 1 X 120 MDNOS | $90.8K | 3 |
| FLUTIAS 125 INHALER (SALMETEROL XINAFOATE 25MCG+FLUTICASONE PROPIONATE 125MCG) 22720 PACK 1 X 120 MDNOS | $90.3K | 3 |
| FLUTIAS 125 INHALER (SALMETEROL XINAFOATE 25MCG+FLUTICASONE PROPIONATE 125MCG ) | $50.0K | 1 |
PT DANKOS FARMA imports 4 distinct Salmeterol formulations from India. The top formulation is FLUTIAS 125 INHALER ( SALMETEROL XINAFOA with 6 shipments worth $300.0K.
Who Are the Top Buyers of Salmeterol from India and How Much Does PT DANKOS FARMA Import?
India exported $22.8M worth of Salmeterol through 7,006 shipments from 148 suppliers to 90 countries, serving 370 buyers globally. PT DANKOS FARMA imports $531.1K of this total, accounting for 0.9% of India's Salmeterol exports with 13 shipments from INDONESIA. This is verified from 13 customs shipment records covering 4 distinct formulations.
What Is the Average Order Value for PT DANKOS FARMA's Salmeterol Imports?
PT DANKOS FARMA's average Salmeterol order value is $40.9K per consignment, based on 13 shipments totaling $531.1K. PT DANKOS FARMA is based in INDONESIA and ranks #17 among all Salmeterol importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Salmeterol to PT DANKOS FARMA?
PT DANKOS FARMA sources Salmeterol from 1 verified Indian supplier: CIPLA LIMITED ($531.1K, 100.0%). This is based on 13 customs records.
How Does PT DANKOS FARMA Compare to Other Salmeterol Importers?
PT DANKOS FARMA ranks #17 among 370 Salmeterol importers from India with a 0.9% market share. The top 3 importers are CIPLA MAROC ($4.4M), PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR ($3.3M), BREATHEFREE LANKA PVT LTD ($2.1M). PT DANKOS FARMA processed 13 shipments from INDONESIA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Salmeterol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Salmeterol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: PT DANKOS FARMA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as PT DANKOS FARMA's capped import value divided by total capped export value for Salmeterol across all Indian exporters.
- 5.Verified Records: This page is backed by 13 individual customs records matching PT DANKOS FARMA importing Salmeterol, covering 4 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 90+ countries, 370+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Salmeterol Import Data for PT DANKOS FARMA
Access order-level details, pricing data, supplier connections, and competitive analysis for PT DANKOS FARMA's Salmeterol imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
PT DANKOS FARMA
Company Profile
Multiple products · $0 total trade · Multiple categories
PT DANKOS FARMA × Salmeterol
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for PT DANKOS FARMA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Salmeterol. For current order-level data, contact TransData Nexus.